Muffy wrote:-SWS wrote:I honestly don't think that CSDB/CompSAS researchers are even close to closing up shop
Me neither, but I believe the focus is less on "Let's get out the Techno-Flash" and more on "Let's figure out what we're doing first."
Good focus IMO.
Muffy wrote:-SWS wrote:"Dang! You mean all we had to do was put our patients on CPAP for 30 days? How did we ever manage to miss that?"
We didn't.
Many kudos for that.
Muffy wrote:-SWS wrote:I think abandoning that CSDB/CompSAS research ship...
They aren't.
Didn't think so.
Muffy wrote:-SWS wrote:1) Disordered plant gain in the above study is proven longitudinally variable rather than fixed,
How does that raise the HMS CompSAS?
Clearly if a Hyoid Myotomy Suspension procedure obviates CPAP, then these patients are happy campers. Seriously, I haven't had time to more carefully analyze. Bear in mind I can chug with physiology, having no real expertise or training...
Muffy wrote:-SWS wrote:2) Purely obstructive patients, in which the central component becomes emergent only after the introduction of CPAP, might prove more adaptable to CPAP than other CSDB/CompSAS patients,
3) Mixed and central patients, in which the central component becomes more severe after the introduction of CPAP, might longitudinally prove more susceptible to a variety of pathogenic factors adversely affecting loop gain,
4) Purely obstructive patients, in which the central component becomes emergent only after the introduction of CPAP, still have an unknown long-term prognosis regarding any distant-future progression of disordered loop-gain,
These points are somewhat confusing to me since any definition of CompSAS
requires treatment-emergent central component.
I thought treatment-emergent central SDB was the CSDB/CompSAS requirement among some prominent researchers---not that the
entire central component must be treatment-emergent. Subtle distinction, but the former allows for central worsening, while the latter excludes central worsening upon treatment.
Muffy wrote:
I would look very carefully at initial therapeutic approach and/or F/U on stable therapy at 1 to 3 months.
I think I already mentioned that I highly doubt you leave your patients with suboptimal therapy. Case in point.
Muffy wrote:That said, there will be some CompSAS patients that need ASV sooner rather than later, but "IMHO" it's a pretty tiny number.
You might be right. Regardless, I'd like to see longitudinal comparisons looking for any disordered loop-gain flareups between the adapted CSDB/CompSAS patients using fixed IPAP (i.e. CPAP & traditional BiLevel) and the CSDB/CompSAS patients using adaptive IPAP (ASV).
Muffy wrote:-SWS wrote:5) More extensive longitudinal studies might actually reveal that supposedly "adapted" CSDB/CompSAS patients periodically present disordered loop-gain flareups,
The anectdotal studies are already there. Search "dial wingin'".
I think the anecdotes might actually reveal this two-fold pattern: 1) disordered loop-gain flare-ups prompting CSDB/CompSAS patients to search for better settings, and 2) that process of searching for better settings often aggravating loop-gain problems---yet occasionally managing to yield better settings. A treatment dilemma IMHO.